MABWELL (SHANGHAI) BIOSCIENCE CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 30.78 CNY | +3.18% |
|
-5.47% | -5.84% |
| 05-24 | Mabwell Announces 9MW2821 Clinical Data | CI |
| 05-13 | Mabwell Announces Clinical Trial Progress of 9MW2821 in Triple-Negative Breast Cancer | CI |
Evolution of the average Target Price on Mabwell (Shanghai) Bioscience Co., Ltd.
Price target over the last 5 years
History of analyst recommendation changes
956eece12bf.qqR4yT-JTNfLNGquLwWDw7bIaTmf5Bo-FuaGXcYrqnk.6fERhEXGfbijUD3WaWewu9qjD37Ph3JQWoXqa6hE_EHQ9RyYU84Cg4AFXg~3f00c7afa114815709575abee7a2f810
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
30.78
CNY
Average target price
48
CNY
Spread / Average Target
+55.95%
High Price Target
48
CNY
Spread / Highest target
+55.95%
Low Price Target
48
CNY
Spread / Lowest Target
+55.95%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
Annual profits - Rate of surprise
- Stock Market
- Equities
- 688062 Stock
- Consensus Mabwell (Shanghai) Bioscience Co., Ltd.
